Boston Commerce Limited
Incorporated in 1995, Boston Bio Systems
Ltd is in the business of trading in goods
e.g. Medical equipment, testing kits,
instruments etc.[1]
- Market Cap ₹ 7.16 Cr.
- Current Price ₹ 10.2
- High / Low ₹ 11.0 / 4.01
- Stock P/E
- Book Value ₹ -1.81
- Dividend Yield 0.00 %
- ROCE -112 %
- ROE -310 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 2.14%
- Company has a low return on equity of -52.4% over last 3 years.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.12 | 0.15 | 0.05 | 0.06 | 1.50 | 0.53 | 0.70 | 0.00 | 0.00 | 0.00 | 0.19 | 0.48 | |
| 0.27 | 0.16 | 0.05 | 0.06 | 1.50 | 0.53 | 0.70 | 0.00 | 0.00 | 0.14 | 0.74 | 7.07 | |
| Operating Profit | -0.15 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.14 | -0.55 | -6.59 |
| OPM % | -125.00% | -6.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -289.47% | -1,372.92% | |||
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.59 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.15 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.14 | -0.55 | -7.18 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||||
| -0.15 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.14 | -0.55 | -7.18 | |
| EPS in Rs | -0.21 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.20 | -0.79 | -10.25 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -11% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 153% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -1205% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 33% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | -28% |
| 3 Years: | -52% |
| Last Year: | -310% |
Balance Sheet
Figures in Rs. Crores
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 |
| Reserves | -0.40 | -0.40 | -0.40 | -0.40 | -0.40 | -0.40 | -0.40 | -0.41 | -0.41 | -0.55 | -1.10 | -8.27 |
| 0.14 | 0.12 | 0.12 | 0.12 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 5.44 | 1.66 | |
| 0.00 | -0.01 | -0.01 | -0.01 | 1.46 | 1.90 | 2.60 | 3.11 | 3.11 | 3.25 | 3.57 | 0.37 | |
| Total Liabilities | 6.74 | 6.71 | 6.71 | 6.71 | 8.93 | 9.37 | 10.07 | 10.57 | 10.57 | 10.57 | 14.91 | 0.76 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 6.74 | 6.71 | 6.71 | 6.71 | 8.93 | 9.37 | 10.07 | 10.57 | 10.57 | 10.57 | 14.91 | 0.76 | |
| Total Assets | 6.74 | 6.71 | 6.71 | 6.71 | 8.93 | 9.37 | 10.07 | 10.57 | 10.57 | 10.57 | 14.91 | 0.76 |
Cash Flows
Figures in Rs. Crores
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | 0.00 | 0.00 | 0.97 | -0.03 | -0.02 | 0.13 | 0.00 | 0.00 | 0.00 | -4.59 | 4.42 | |
| 0.00 | 0.00 | 0.00 | -0.91 | 0.00 | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.58 | -4.38 | |
| Net Cash Flow | 0.00 | 0.00 | 0.00 | 0.06 | -0.03 | -0.02 | 0.05 | 0.00 | 0.00 | 0.00 | -0.01 | 0.04 |
| Free Cash Flow | 1.00 | 0.00 | 0.00 | 0.97 | -0.03 | -0.02 | 0.13 | 0.00 | 0.00 | 0.00 | -4.59 | 4.42 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | -667% | 0% | 0% | 835% | -67% |
Ratios
| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 362.57 | 1,342.92 | 1,308.79 | 5,532.63 | 0.00 | |||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 11.59 | 0.00 | ||||||
| Days Payable | 1,488.97 | |||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 362.57 | 1,342.92 | -168.60 | 5,532.63 | 0.00 | |||
| Working Capital Days | -425.83 | -292.00 | -876.00 | 4,745.00 | 226.30 | 661.13 | 453.64 | 10,585.00 | 235.73 | |||
| ROCE % | -2.05% | -0.15% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1.89% | -5.89% | -112.36% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Inventory of goods (Stock of Soil) INR lacs |
|
|||
| Number of permanent employees count |
||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September 2026
-
Change In Domain Name Of Website Of The Company
- Boston Commerce Limited changed its website domain from bostonbio.in to bostoncommerce.net.
-
Submission Of Voting Results Under Regulation 44(3) Of The SEBI (LODR) Regulations, 2015 Of AGM Held On 30Th September 2026
- Boston Commerce AGM voting results: all 5 resolutions passed on 30 September 2026, including director and auditor appointments.
-
Submission Of Scrutinizer''''s Report Of AGM Held On 30Th September 2026.
- Submitted Consolidated Scrutinizer's Report for AGM held on 30 September 2026.
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- 31st AGM held on September 30, 2026; five ordinary resolutions considered, voting results pending.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
-
Annual Report 2010
from bse
-
Annual Report 2000
from bse
-
Annual Report 1999
from bse
Business Overview:[1]
BBSL specializes in jobwork for herbal and health-related products for formulation companies. Company also has plans to enter the medical field which includes the sales and servicing of medical equipment